Contents search : Emily Farrow. Genetics in Medicine 23 , - ERS Respiratory Channel (2024)

Panel discussion on genetics in pulmonary fibrosis

This webinar took place on 5 April, 2023. Chair:Prof. Katerina Antoniou (Heraklion, Greece)Speakers:Dr. Raphaël Borie (Paris, France), Coline van Moorsel (Nieuwegein, Netherlands);EU-PFF patient representative: Clare Beckett;Discussant: Dr. Francesco Bonella (Düsseldorf, Germany) Pulmonary fibrosis is a devastating form of ILD and around 20% of patients have a genetic form of pulmonary fibrosis which associates with worse survival, comorbidities, and increased risk for disease in family members. Recognition of these patients and genetic analysis informs on diagnosis, prognosis, risk for comorbidities, treatment response and disease risk assessment in relatives. A patient, relatives and pulmonologist's survey conducted by the ERS taskforce members showed a high need for education among patients and pulmonologists. The ERS taskforce TF 2019-10 Genetics in pulmonary fibrosis provided a statement to inform clinicians on current knowledge and expert practice. Educational aims The webinar explained what genetic pulmonary fibrosis is, and informed the audience on: The patient's trajectory: experiences and needsEpidemiology, pathogenesis (genes involved) and phenotype of genetic pulmonary fibrosisPrognosis, treatment options and expected comorbidities in patients with genetic pulmonary fibrosisRelatives at increased risk for disease and screening for early disease Topics How to recognize a patient suspected of genetic pulmonary fibrosis?Which patients may benefit from genetic testing?Management of relatives at risk: genetic testing and/or physical screening? Learning outcomes Following this webinar, participants will now be up to date on cause, frequency, phenotype and management of genetic pulmonary fibrosis which will enable them to recognise putative patients with the disease and optimize their management.

05 Apr 2023

Academy of paediatric respiratory medicine - part one

To take part in this event, you must register in advance. REGISTER NOW Access the live stream WATCH LIVE Part 1: 27-29 June, 2023 | OnlineThe Academy of paediatric respiratory medicine is intended to provide a comprehensive overview of each of the major fields of paediatric respiratory medicine, based on the HERMES syllabus. This academy is aimed at all paediatric respiratory professionals wishing to update their knowledge, particularly those preparing for theEuropean examination in paediatric respiratory medicine.Learning outcomesFollowing this course, participants will gain detailed knowledge of:The major fields of paediatric respiratory medicineThe HERMES syllabus modulesBest practice in how to prepare for the European examination in paediatric respiratory medicineAcademy modulesAcute respiratory infectionsAirway endoscopyBronchial asthma and wheezing disordersChronic respiratory failureCongenital malformationsCystic fibrosisEvaluation of respiratory signs and symptomsLung function testingLung imagingRare diseases and lung transplantationSleep medicineTuberculosis

14 Jun 2023

Academy of paediatric respiratory medicine 2024 - Part one

To take part in this event, you must register in advance. REGISTER NOW 18-20 June, 2024 | Online The Academy of paediatric respiratory medicine is intended to provide a comprehensive overview of each of the major fields of paediatric respiratory medicine, based on the HERMES syllabus. This academy is aimed at all paediatric respiratory professionals wishing to update their knowledge, particularly those preparing for the European examination in paediatric respiratory medicine. The course programme is designed to challenge participants and provide a learning framework. It includes interactive case-based sessions and discussions, lectures with key updates in the field, a Q&A session for participants, and a broad selection of pre-recorded lectures. Participants will have the opportunity to review online learning modules at their own pace before attending part one, online from 18-20 June, 2024. Part two will take place during the ERS Congress 2024 in Vienna, Austria and will consist of case-based sessions where medical practitioners will have the opportunity to align their current procedures with the latest clinical best practice. The aim of these sessions is to disseminate established practices with dedicated time for one-to-one interaction between participants and faculty. Participants may register for Part one (Online) exclusively or Part one (Online) + Part two (Vienna). Academy modules Airway endoscopy Acute respiratory infections Congenital malformations Lung function testing Bronchial asthma and wheezing disorders Imaging and sleep medicine Cystic fibrosis, protracted bacterial bronchitis and non-CF bronchiectasis Tuberculosis Rare diseases Course format Pre-recorded online modules Part one: Lectures with key updates, interactive polls and Q&A discussion time Case-based sessions Please note that all timings are in Central European Summer Time (CEST). Recordings of each session will be made available to registered participants within two weeks after the event, with the exception of the on-site sessions in Vienna, Austria.Replays will remain accessible until December 2024 on the ERS Respiratory Channel. Learning outcomes Following this course, participants will gain detailed knowledge of: The major fields of paediatric respiratory medicine The HERMES syllabus modules Best practice in how to prepare for the European examination in paediatric respiratory medicine Accreditation Part one of the Academy event has been accredited with 17.5 CME credits by the European Board for Accreditation in Pneumology (EBAP).

29 May 2024

Academy of adult respiratory medicine - part one

To take part in this event, you must register in advance. REGISTER NOW Access the live stream WATCH LIVE Part 1: 27-29 June, 2023 | Online The Academy of adult respiratory medicine is intended to provide a comprehensive overview of each of the major fields of respiratory medicine based on the HERMES syllabus. This academy is aimed at all respiratory professionals wishing to update their knowledge, particularly those preparing for theEuropean examination in adult respiratory medicine. The programme is designed to challenge participants and provide a learning framework, and includes interactive case-based sessions, workshops and Q&A discussion sessions. Learning outcomes Following this course participants will gain detailed knowledge of: The major fields of respiratory medicineThe HERMES syllabus modulesBest practice in how to prepare for the European examination in adult respiratory medicine Academy modules Pulmonary function testingRespiratory failureLung imagingRespiratory infections and tuberculosisPleural, mediastinal and chest wall diseasesThoracic tumoursAirway diseasesPulmonary vascular diseasesInterstitial lung diseasesSleep-related disordersSmoking cessation (new in 2023)Pulmonary rehabilitation (new in 2023)

14 Jun 2023

Academy of adult respiratory medicine 2024 - Part one

To take part in this event, you must register in advance. REGISTER NOW 18-20 June, 2024 | Online Overview The Academy of adult respiratory medicine is intended to provide a comprehensive overview of each of the major fields of respiratory medicine based on the HERMES syllabus. This academy is aimed at all respiratory professionals wishing to update their knowledge, particularly those preparing for the European examination in adult respiratory medicine. The programme is designed to challenge participants and provide a learning framework, including pre-course online learning modules for participants to review at their own pace before attending Part one online. Part two will take place during the ERS Congress in Vienna, Austria and it will consist of case-based sessions in which participants will put knowledge into practice by taking part in group tasks led by the faculty. Participants may register for Part one (Online) exclusively or Part one (Online) + Part two (Vienna). Academy modules Pulmonary function testing Respiratory failure Lung imaging Respiratory infections and tuberculosis Pleural, mediastinal and chest wall diseases Thoracic tumours Airway diseases Pulmonary vascular diseases Interstitial lung diseases Sleep-related disorders Smoking cessation (new in 2023) Pulmonary rehabilitation (new in 2023) Course format Pre-recorded online modules Part one (Online): Live streamed lectures Multiple-choice questions Discussion and Q&A Please note that all timings are in Central European Summer Time (CEST). Recordings of each session will be made available to registered participants within two weeks after the event, with the exception of the on-site sessions in Vienna, Austria.Replays will remain accessible until December 2024 on the ERS Respiratory channel. Learning outcomes Following this course participants will gain detailed knowledge of: The major fields of respiratory medicine The HERMES syllabus modules Best practice in how to prepare for the European examination in adult respiratory medicine Accreditation Part one of the Academy has been accredited with 19.5 CME credits by the European Board for Accreditation in Pneumology (EBAP):

29 May 2024

Oral corticosteroid therapy in asthma: key messages

Overview Taking place on 5 July, this ERS Vision Live panel discussion focused on oral corticosteroid therapy in asthma. The expert panellists discussed key areas, including: The morbidity burden of oral corticosteroid therapy in asthma.Type-2 biologics to reduce oral corticosteroids in asthma.What should our aspirations be for our asthma patients? Prof. Joanna Chorostowska-Wynimko, ERS Secretary General, Professor of Medicine, Head of the Department of Genetics and Clinical Immunology and a Consultant in Respiratory Medicine at the National Institute of Tuberculosis and Lung Diseases (NITLD) in Warsaw, Poland hosted this addition of ERS Vision Live. Following the first International Respiratory (IRC) Coalition Summit, Prof. Chorostowska-Wynimko provided information on how the IRC aims to transform respiratory care and improve outcomes of people living with asthma and other conditions. Chairs Prof. Liam Heaney Liam Heaney is Professor of Respiratory Medicine at Queens University Belfast, who trained in Northern Ireland and the Royal Brompton Hospital in London.He is Director of the Northern Ireland Regional Difficult Asthma Service.He has chaired the British Thoracic Society Specialist Advisory Group for Asthma, the Evidence Review Group for Difficult Asthma for the British Thoracic Society / Scottish Intercollegiate Guideline on Asthma Management and has been a member of the National Steering Committee for the UK Asthma Guidelines.He coordinates the UK Severe Asthma Registry and is Academic Lead for the Medical Research Council UK Refractory Stratification Programme. Prof. Renaud Louis Renaud Louis is full professor, academic head of the department of respiratory medicine at University of Liege and CHU of Liege, Belgium since 2004.He was president of the Belgian Thoracic Society from 2013 until 2014 and he served as secretary of the group 5.3 allergy and Immunology of the assembly 5 "Airway diseases" at the ERS from 2002 until 2005.He currently sits in the steering committee of the SHARP (ERS research project on Severe Asthma) and is co-chair of the current ERS task force on "Diagnosis in asthma in adults".He has focused his clinical research on asthma for 30 years developing the technique of induced sputum as a research tool to investigate mechanisms of airway inflammation but also applying it in clinical practice as an aid to asthma management. Speakers Prof. David Price David Price is Professor of Primary Care Respiratory Medicine at the University of Aberdeen, UK.He is the founder and Head of The Observational and Pragmatic Research Institute (OPRI) in Singapore and is the Managing Director of Optimum Patient Care Global in Australia and UK.Professor Price established the Optimum Patient Care Research Database (OPCRD), one of the largest enhanced healthcare databases holding anonymous data from over 800 general practices and approximately 11 million patients in the UK. Dr. David Jackson David Jackson is an Associate Professor in Respiratory Medicine at King's College London and Head of the Severe Asthma and Eosinophilic Lung Disease Service at Guy's and St Thomas' Hospitals in London.He has an MSc in Allergy and a PhD in the pathophysiology of asthma exacerbations and has published widely in the field of type 2 immunity, biologic therapies in asthma, and the mechanisms of virus-induced asthma exacerbations.He was the editor of the ERS Monograph book on Eosinophilic Lung Diseases, is an Associate Editor at the journal ALLERGY, the Reviews Editor at CHEST, and is about to start a term as Associate editor at THORAX. Prof. Andrew Menzies-Gow Andrew Menzies-Gow is a consultant respiratory physician specialising in severe asthma and Director of the Lung Division at Royal Brompton and Harefield Hospitals, London, UK.He is a Professor of Practice (Respiratory Medicine) at Imperial College, London, UK where his research interests focus on novel therapies for asthma and eosinophilic lung disease.

05 Jul 2022

The Innovative Medicines Initiative (IMI), a promising partnership to deliver new medicines to patients

Thursday, 8 May 2008

08 May 2008

Tomorrow’s medicine today: overview of personalised medicine and insights into tomorrow’s world

03 Sep 2016

Alpha-1 antitrypsin deficiency (AATD)

Overview Taking place on 21 February, this ERSVision Live panel discussion focused on Alpha-1 antitrypsin deficiency (AATD). The expert panellists discussed key areas, including: The consequences of polymerized Alpha-1-antitrypsin in the liver and the circulation,The challenges for the diagnosis of AATD,And the treatment-related specificities of AATD. Chairs: Prof. Nicolas Roche Nicolas is Professor of Respiratory Medicine at Paris Cité University and Head of the Respiratory Medicine Department at Cochin Hospital, Paris. He is the current ERS Science Council chair and has been Guidelines Director at ERS.He is a member of the Science Committee of the Global Initiative for Obstructive Lung Disease and has contributed to several other international guidelines on various aspects of COPD. Dr Marc Miravitlles Marc is a Senior Researcher and Consultant at Vall d'Hebron University Hospital in Barcelona. He was Chair of the Respiratory Infections Group of the European Respiratory Society (ERS) and Guidelines Director of the ERS.He has acted as a consultant for the development of international guidelines of COPD, including the ERS statement on management of respiratory disease in Alpha-1 antitrypsin deficiency (AATD) and is the current Chair of the European Alpha-1- Research Collaboration (EARCO CRC) of the ERS. Speakers Prof. Jan Stolk Jan has been Associate Professor of Respiratory Medicine at Leiden University Medical Center (LUMC) since 1992, with main interest in Alpha-1-antitrypsin deficiency (AATD). He has also been Director of Patient Care Path at LUMC for all clinical aspects of AATD, including liver and skin disease, since 2019. He is Chair of Core Network for AATD of the European Reference Network (ERN) for the lung (ERN-LUNG). Prof. Alice Turner Alice has been a Consultant in Respiratory Medicine at Heartlands Hospital since 2011, and Professor of Respiratory Medicine at University of Birmingham since 2020.She plays an active role with specialist societies, having been a member of the British Thoracic Society Specialist Advisory Group on COPD, and is currently a member of their Quality Improvement Committee.She has published widely in COPD and AATD, and has ongoing research projects funded by the NIHR, Alpha 1 Foundation amongst others. Prof. Ilaria Ferrarotti Ilaria is Assistant Professor at the University of Pavia, Department of Internal Medicine and Therapeutics in the Pulmonology Unit, in Italy where she conducts research, lectures, and coordinates the diagnostic activity of the Reference Centre of Diagnosis of Alpha-1 Antitrypsin Deficiency (AATD).Her main areas of scientific interest include the genetics of respiratory diseases, in particular AATD and COPD.She is currently member of the Steering Committee of European Alpha-1 Research Collaboration (EARCO) group of ERS.

22 Feb 2023

Effect of COVID 19 restrictive measures on tobacco, cigarette or e-cigarette consumption

07 Sep 2021

Talk from Athens – Genetics: diagnosing, counseling, and optimising therapy in fibrotic lung diseases

10 Apr 2019

Genetics of childhood versus adult asthma: common and unique factors

27 Mar 2013

Assessing genetics of complex traits

27 Mar 2013

LYMPHANGIOLEIOMYOMATOSIS AND GENETICS

04 Sep 2022

Genetics in pulmonary arterial hypertension

05 Sep 2022

An international surveyon genetics in clinical practice for interstitial lung disease.

06 Sep 2021

The role of genetics in diagnosing primary ciliarydyskinesia (PCD) in pediatric patients inGothenburg, Sweden.

07 Sep 2021

Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)

08 Sep 2021

Genetics of response to sustained-release morphine for chronic breathlessness - an exploratory study

24 Aug 2020

The genetics of asthma and the promise of genomics-guided drug discovery

08 Sep 2020

Contents search : Emily Farrow. Genetics in Medicine 23 , - ERS Respiratory Channel (2024)
Top Articles
Latest Posts
Article information

Author: Chrissy Homenick

Last Updated:

Views: 6384

Rating: 4.3 / 5 (74 voted)

Reviews: 89% of readers found this page helpful

Author information

Name: Chrissy Homenick

Birthday: 2001-10-22

Address: 611 Kuhn Oval, Feltonbury, NY 02783-3818

Phone: +96619177651654

Job: Mining Representative

Hobby: amateur radio, Sculling, Knife making, Gardening, Watching movies, Gunsmithing, Video gaming

Introduction: My name is Chrissy Homenick, I am a tender, funny, determined, tender, glorious, fancy, enthusiastic person who loves writing and wants to share my knowledge and understanding with you.